Presentation
Myolax 50: Each film coated tablet contains Tolperisone Hydrochloride INN 50 mg.
Description
Tolperisone Hydrochloride is a centrally acting muscle relaxant. It effectively reduces muscular hypertonicity, improves peripheral blood flow by vasodilatation and reduces pain.
Indications
Increased tone of skeletal muscles due to organic neurological disorders (e.g. injury of the pyramidal tract, multiple sclerosis, myelopathy, encephalomyelitis etc.), muscular hypertension, muscular spasm, muscular contracture, rigidity, spinal automatism and discopathy. Obliterative vascular diseases (obliterative arteriosclerosis, diabetic angiopathy, obliterative thromboangitis, Raynaud\s disease, diffuse scleroderma) and disorders due to injured innervation of the vessels (acrocyanosis, intermittent angioneurotic dysbasia). In individual cases post-thrombotic venous and lymphatic circulation disorders, crural ulcer
Dosage & Administration
One should follow doctor\s instructions regarding the dosage of Myolax. The recommended dose is as followings:
Tablet
Adult: 50-150 mg three times daily according to the individual requirement and tolerance of the patient.
Children (from 3 months to 6 years): 5-10 mg/kg/day in three divided doses.
Children (from 6 to 14 years): 2-4 mg/kg/day in three divided doses.
Side Effects
Sometimes, muscular weakness, headache, nausea, vomiting and rarely hypersensitivity reactions may occur as side effects
Precautions
In case of children, the prescribed dose and duration of treatment should closely be observed
Use in Pregnancy & Lactation
Tolperisone hydrochloride should be used in pregnancy according to physician\s advice. Tolperisone hydrochloride should not be used during breast feeding
Drug Interaction
Concomitant use of methocarbamol with tolperisone hydrochloride has been reported to cause disturbance of visual accommodation.
Over Dose
In the event of over dosage supportive therapy may be substituted
Commercial Pack
Myolax 50: Each box contains 10 blister strips of 10 tablets.
Brand: Incepta Pharmaceuticals Ltd
